Bendazac

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

苯达扎克是一种抗白内障化合物。它可能通过防止蛋白质变性来起作用。

Bendazac is an anticataract drug. It may act by preventing protein denaturation.(In Vitro):Bendazac is an anti-inflammatory agent endowed with protein antidenaturant properties effective for various inflammatory skin conditions. Bendazac has been shown to be a strong reacting substrate in a chemical oxidizing system, which mimics a physiological pathway of hydroxy radical generation.By using EPR spectroscopy of spin-labelled bovine serum albumin (BSA), Bendazac was shown to prevent the BSA denaturation induced by urea, heat and free radicals produced in the xanthine/xanthine oxidase system.

——

——

Bendazolic acid | AF-983

Others

Other Targets

Others

——

——

20187-55-7

282.29

C16H14N2O3

>98% (HPLC)

DMSO:56 mg/mL (198.38 mM)

O=C(O)COc1nn(Cc2ccccc2)c2ccccc12

2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid

(-20℃)

With Ice Pack

≥ 2 years